Researchers found that cholera toxin B subunit binds with high affinity to human T and B lymphocytes, and that this binding is specifically blocked by thymosin alpha-1, interferon alpha, and a short peptide called LKEKK. Both cholera toxin B and the LKEKK peptide increased the activity of an enzyme called soluble guanylate cyclase in these immune cells, suggesting they share a common receptor.
Navolotskaya, Elena V; Sadovnikov, Vladimir B; Zinchenko, Dmitry V; Lipkin, Valery M; Zav'yalov, Vladimir P